Ani Pharmaceuticals (ANIP) Net Income Growth (5y) (2016 - 2026)
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Net Income Growth (5y) (2016 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn |
| 2 | Viatris | 19.20 Bn | 18.31 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.73 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.49 Bn | 5.36 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.31 Bn | 475.75 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 711.29 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 396.40 Mn | 355.15 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.22% |
| Mar 31, 2026 | 205.96% |
| Dec 31, 2025 | 57.25% |
| Sep 30, 2025 | 124.83% |
| Jun 30, 2025 | 21.88% |
| Mar 31, 2025 | 33.50% |
| Dec 31, 2024 | -16.27% |
| Sep 30, 2024 | -52.10% |
| Jun 30, 2024 | -18.61% |
| Mar 31, 2024 | 109.70% |
| Dec 31, 2023 | -26.62% |
| Sep 30, 2023 | 14.50% |
| Jun 30, 2023 | 17.61% |
| Mar 31, 2023 | -8.11% |
| Dec 31, 2022 | -17.42% |
| Sep 30, 2022 | -25.16% |
| Jun 30, 2022 | -37.18% |
| Mar 31, 2022 | -61.96% |
| Dec 31, 2021 | -62.53% |
| Sep 30, 2021 | -20.94% |